🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Short Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease.

RecruitingNAAges 18 Years - anyAllUniversity Ghent
NCT07863219 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood. The main questions it aims to answer are: * Does a 10-week RGM intervention improve cognitive aspects, speech (indirectly through improved breathing), mobility, and balance in participants with Parkinson's disease? * How do participants experience the intensity, difficulty, and emotional impact of the RGM sessions?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * diagnosis of idiopathic Parkinson's disease * safe, independent mobility and participation (Hoehn and Yahr stages 1-3) * a stable dopaminergic medication regimen for at least 4 weeks prior to study participation * willingness and ability to participate in a 10-week intervention program * willingness to participate in the study (signing of informed consent) Exclusion Criteria: * Presence of other neurological or severe psychiatric conditions that could interfere with participation or the interpretation of results (e.g., substance use disorder, severe depression, psychosis) * Severe visual or hearing impairments that limit the ability to follow group instructions as determined by a physician. * Physical limitations that inhibit safe participation in moderate-to-vigorous exercise or group rehabilitation.
💊

What it tests

  • Ronnie Gardiner Method
📍

Where

1 site
University Hospital Ghent
Ghent, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy